Related references
Note: Only part of the references are listed.Mobilization of iron from ferritin: new steps and details
A. La et al.
METALLOMICS (2018)
Di-2-pyridylhydrazone Dithiocarbamate Butyric Acid Ester Exerted Its Proliferative Inhibition against Gastric Cell via ROS-Mediated Apoptosis and Autophagy
Xingshuang Guo et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2018)
Antiproliferative activity of di-2-pyridylhydrazone dithiocarbamate acetate partly involved in p53 mediated apoptosis and autophagy
Tingting Wang et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2017)
The antiproliferative activity of di-2-pyridylketone dithiocarbamate is partly attributed to catalase inhibition: detailing the interaction by spectroscopic methods
Cuiping Li et al.
MOLECULAR BIOSYSTEMS (2017)
Calcium release induced by 2-pyridinecarboxaldehyde thiosemicarbazone and its copper complex contributes to tumor cell death
Yun Fu et al.
ONCOLOGY REPORTS (2017)
Palmitic Acid Curcumin Ester Facilitates Protection of Neuroblastoma against Oligomeric Aβ40 Insult
Zhangyang Qi et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2017)
Iron and Neurodegeneration: Is Ferritinophagy the Link?
Giorgio Biasiotto et al.
MOLECULAR NEUROBIOLOGY (2016)
Recent advances in cancer treatment by iron chelators
Vincent Corce et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2016)
Reduced autophagy leads to an impaired ferritin turnover in senescent fibroblasts
Christiane Ott et al.
FREE RADICAL BIOLOGY AND MEDICINE (2016)
Mechanisms of Selective Autophagy in Normal Physiology and Cancer
Joseph D. Mancias et al.
JOURNAL OF MOLECULAR BIOLOGY (2016)
Iron-Mediated Lysosomal Membrane Permeabilization in Ethanol-Induced Hepatic Oxidative Damage and Apoptosis: Protective Effects of Quercetin
Yanyan Li et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2016)
MCOLN1 is a ROS sensor in lysosomes that regulates autophagy
Xiaoli Zhang et al.
NATURE COMMUNICATIONS (2016)
Iron chelators target both proliferating and quiescent cancer cells
Marten Fryknas et al.
SCIENTIFIC REPORTS (2016)
Antitumor activity of endoperoxide-iron chelator conjugates-design, synthesis and biological evaluation
Xing Yan et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2015)
The antitumor mechanism of di-2-pyridylketone 2-pyridine carboxylic acid hydrazone and its copper complex in ROS generation and topoisomerase inhibition, and hydrazone involvement in oxygen-catalytic iron mobilization
Tengfei Huang et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2015)
Role of lipid peroxidation derived 4-hydroxynonenal (4-HNE) in cancer: Focusing on mitochondria
Huiqin Zhong et al.
REDOX BIOLOGY (2015)
Oxidative Stress and the Homeodynamics of Iron Metabolism
Nikolaus Bresgen et al.
BIOMOLECULES (2015)
Inhibition of autophagy enhances the anticancer activity of silver nanoparticles
Jun Lin et al.
AUTOPHAGY (2014)
Quantitative proteomics identifies NCOA4 as the cargo receptor mediating ferritinophagy
Joseph D. Mancias et al.
NATURE (2014)
The role of iron and reactive oxygen species in cell death
Scott J. Dixon et al.
NATURE CHEMICAL BIOLOGY (2014)
Lysosomal Iron, Iron Chelation, and Cell Death
Alexei Terman et al.
ANTIOXIDANTS & REDOX SIGNALING (2013)
The Autophagy Inhibitor Verteporfin Moderately Enhances the Antitumor Activity of Gemcitabine in a Pancreatic Ductal Adenocarcinoma Model
Elizabeth Donohue et al.
JOURNAL OF CANCER (2013)
Mechanisms of Mammalian Iron Homeostasis
Kostas Pantopoulos et al.
BIOCHEMISTRY (2012)
Substituent Effects on Desferrithiocin and Desferrithiocin Analogue Iron-Clearing and Toxicity Profiles
Raymond J. Bergeron et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Desferrithiocin analogue iron chelators: iron clearing efficiency, tissue distribution, and renal toxicity
Raymond J. Bergeron et al.
BIOMETALS (2011)
Oxygen catalyzed mobilization of iron from ferritin by iron(III) chelate ligands
Fadi Bou-Abdallah et al.
CHEMICAL COMMUNICATIONS (2011)
Artesunate Activates Mitochondrial Apoptosis in Breast Cancer Cells via Iron-catalyzed Lysosomal Reactive Oxygen Species Production
Anne Hamacher-Brady et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Distinct Mechanisms of Ferritin Delivery to Lysosomes in Iron-Depleted and Iron-Replete Cells
Takeshi Asano et al.
MOLECULAR AND CELLULAR BIOLOGY (2011)
Specific iron chelators determine the route of ferritin degradation
Ivana De Domenico et al.
BLOOD (2009)
Downregulation of ferritin heavy chain increases labile iron pool, oxidative stress and cell death in cardiomyocytes
Shigemiki Omiya et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2009)
Systemic Iron Homeostasis and the Iron-Responsive Element/Iron-Regulatory Protein (IRE/IRP) Regulatory Network
Martina U. Muckenthaler et al.
Annual Review of Nutrition (2008)
The type IV mucolipidosis-associated protein TRPML1 is an endolysosomal iron release channel
Xian-Ping Dong et al.
NATURE (2008)
TRPML and lysosomal function
David A. Zeevi et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2007)
Future of toxicology-iron chelators and differing modes of action and toxicity: The changing face of iron chelation therapy
Danuta S. Kalinowski et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2007)
Iron-binding properties of plant phenolics and cranberry's bio-effects
Maolin Guo et al.
DALTON TRANSACTIONS (2007)
Ferroportin-mediated mobilization of ferritin iron precedes ferritin degradation by the proteasome
Ivana De Domenico et al.
EMBO JOURNAL (2006)
A class of iron chelators with a wide spectrum of potent antitumor activity that overcomes resistance to chemotherapeutics
Megan Whitnall et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Intracellular labile iron pools as direct targets of iron chelators: a fluorescence study of chelator action in living cells
H Glickstein et al.
BLOOD (2005)
Release of iron from ferritin by aceto- and benzohydroxamic acids
N Gálvez et al.
INORGANIC CHEMISTRY (2005)
The labile iron pool: Characterization, measurement, and participation in cellular processes
O Kakhlon et al.
FREE RADICAL BIOLOGY AND MEDICINE (2002)